Utility of Integrated HIV-1 Dna Quantification in Cure Studies

References

• Palmer S , MaldarelliF, WiegandAet al. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy . Proc. Natl Acad. Sci. USA105 ( 10 ), 3879 – 3884 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Chun TW , NickleDC, JustementJSet al. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy . J. Infect. Dis.197 ( 5 ), 714 – 720 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Sturdevant CB , JosephSB, SchnellG, PriceRW, SwanstromR, SpudichS . Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection . PLoS Pathog.11 ( 3 ), e1004720 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Alexaki A , LiuY, WigdahlB . Cellular reservoirs of HIV-1 and their role in viral persistence . Curr. HIV Res.6 ( 5 ), 388 – 400 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Banga R , ProcopioFA, NotoAet al. PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals . Nat. Med.22 ( 7 ), 754 – 761 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Chavez L , CalvaneseV, VerdinE . HIV Latency is established directly and early in both resting and activated primary CD4 T cells . PLoS Pathog.11 ( 6 ), e1004955 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Siliciano JM , SilicianoRF . The remarkable stability of the latent reservoir for HIV-1 in resting memory CD4+ T cells . J. Infect. Dis.212 ( 9 ), 1345 – 1347 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Pierson T , McarthurJ, SilicianoRF . Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy . Annu. Rev. Immunol.18, 665 – 708 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Whitney JB , HillAL, SanisettySet al. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys . Nature512 ( 7512 ), 74 – 77 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Malatinkova E , De SpiegelaereW, BonczkowskiPet al. Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs . eLife4, e09115 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Finzi D , BlanksonJ, SilicianoJDet al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy . Nat. Med.5 ( 5 ), 512 – 517 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Chun TW , StuyverL, MizellSBet al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy . Proc. Natl Acad. Sci. USA94 ( 24 ), 13193 – 13197 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Wong JK , HezarehM, GunthardHFet al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia . Science278 ( 5341 ), 1291 – 1295 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Chomont N , El-FarM, AncutaPet al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation . Nat. Med.15 ( 8 ), 893 – 900 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Wagner TA , McLaughlinS, GargKet al. HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection . Science345 ( 6196 ), 570 – 573 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Siliciano RF , GreeneWC . HIV latency . Cold Spring Harb. Perspect. Med.1 ( 1 ), a007096 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Fletcher CV , StaskusK, WietgrefeSWet al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues . Proc. Natl Acad. Sci. USA111 ( 6 ), 2307 – 2312 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lorenzo-Redondo R , FryerHR, BedfordTet al. Persistent HIV-1 replication maintains the tissue reservoir during therapy . Nature530 ( 7588 ), 51 – 56 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Battistini A , SgarbantiM . HIV-1 latency: an update of molecular mechanisms and therapeutic strategies . Viruses6 ( 4 ), 1715 – 1758 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Savarino A , MaiA, NorelliSet al. “Shock and kill” effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence . Retrovirology6, 52 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Margolis DM . Histone deacetylase inhibitors and HIV latency . Curr. Opin. HIV AIDS6 ( 1 ), 25 – 29 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Campbell GR , BruckmanRS, ChuYL, SpectorSA . Autophagy induction by histone deacetylase inhibitors inhibits HIV type 1 . J. Biol. Chem.290 ( 8 ), 5028 – 5040 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Spivak AM , PlanellesV . HIV-1 eradication: early trials (and tribulations) . Trends Mol. Med.22 ( 1 ), 10 – 27 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Bruner KM , HosmaneNN, SilicianoRF . Towards an HIV-1 cure: measuring the latent reservoir . Trends Microbiol.23 ( 4 ), 192 – 203 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Eriksson S , GrafEH, DahlVet al. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies . PLoS Pathog.9 ( 2 ), e1003174 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chun TW , CarruthL, FinziDet al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection . Nature387 ( 6629 ), 183 – 188 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Zhu W , JiaoY, LeiRet al. Rapid turnover of 2-LTR HIV-1 DNA during early stage of highly active antiretroviral therapy . PLoS ONE6 ( 6 ), e21081 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Pace MJ , GrafEH, O’dohertyU . HIV 2-long terminal repeat circular DNA is stable in primary CD4+T cells . Virology441 ( 1 ), 18 – 21 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Koelsch KK , LiuL, HaubrichRet al. Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro . J. Infect. Dis.197 ( 3 ), 411 – 419 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Sharkey M , BabicDZ, GreenoughT, GulickR, KuritzkesDR, StevensonM . Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure . PLoS Pathog.7 ( 2 ), e1001303 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Murray JM , McbrideK, BoeseckeCet al. Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards . AIDS26 ( 5 ), 543 – 550 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kiselinova M , De SpiegelaereW, BuzonMJ, MalatinkovaE, LichterfeldM, VandekerckhoveL . Integrated and total HIV-1 DNA predict ex vivo viral outgrowth . PLoS Pathog.12 ( 3 ), e1005472 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Pasternak AO , LukashovVV, BerkhoutB . Cell-associated HIV RNA: a dynamic biomarker of viral persistence . Retrovirology10, 41 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Procopio FA , FromentinR, KulpaDAet al. A novel assay to measure the magnitude of the inducible viral reservoir in HIV-infected individuals . EBioMedicine2 ( 8 ), 874 – 883 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Mexas AM , GrafEH, PaceMJet al. Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials . AIDS26 ( 18 ), 2295 – 2306 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Izopet J , CazabatM, PasquierCet al. Evolution of total and integrated HIV-1 DNA and change in DNA sequences in patients with sustained plasma virus suppression . Virology302 ( 2 ), 393 – 404 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Williams JP , HurstJ, StohrWet al. HIV-1 DNA predicts disease progression and post-treatment virological control . eLife3, e03821 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Koelsch KK , BoeseckeC, McbrideKet al. Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir . AIDS25 ( 17 ), 2069 – 2078 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Siliciano JD , KajdasJ, FinziDet al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells . Nat. Med.9 ( 6 ), 727 – 728 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Ho YC , ShanL, HosmaneNNet al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure . Cell155 ( 3 ), 540 – 551 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Graf EH , MexasAM, YuJJet al. Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off HAART . PLoS Pathog.7 ( 2 ), e1001300 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Graf EH , O’dohertyU . Quantitation of integrated proviral DNA in viral reservoirs . Curr. Opin. HIV AIDS8 ( 2 ), 100 – 105 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Azzoni L , FoulkesAS, PapasavvasEet al. Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration . J. Infect. Dis.207 ( 2 ), 213 – 222 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Soriano-Sarabia N , BatesonRE, DahlNPet al. Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells . J. Virol.88 ( 24 ), 14070 – 14077 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Van Lint C , BouchatS, MarcelloA . HIV-1 transcription and latency: an update . Retrovirology10, 67 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Rezaei SD , CameronPU . Human immunodeficiency virus (HIV)-1 integration sites in viral latency . Curr. HIV/AIDS Rep.12 ( 1 ), 88 – 96 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Bruner KM , MurrayAJ, PollackRAet al. Defective proviruses rapidly accumulate during acute HIV-1 infection . Nat. Med.22 ( 9 ), 1043 – 1049 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Laird GM , EiseleEE, RabiSAet al. Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay . PLoS Pathog.9 ( 5 ), e1003398 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Siliciano JD , SilicianoRF . Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals . Methods Mol. Biol.304, 3 – 15 ( 2005 ).
   PubMedGoogle Scholar
• Hatano H , JainV, HuntPWet al. Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells . J. Infect. Dis.208 ( 1 ), 50 – 56 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Liszewski MK , YuJJ, O’dohertyU . Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR . Methods47 ( 4 ), 254 – 260 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Avettand-Fenoel V , ChaixML, BlancheSet al. LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01) . J. Med. Virol.81 ( 2 ), 217 – 223 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• van der Sluis RM , van MontfortT, CentlivreMet al. Quantitation of HIV-1 DNA with a sensitive TaqMan assay that has broad subtype specificity . J. Virol. Methods187 ( 1 ), 94 – 102 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Strain MC , LadaSM, LuongTet al. Highly precise measurement of HIV DNA by droplet digital PCR . PLoS ONE8 ( 4 ), e55943 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Vandergeeten C , FromentinR, MerliniEet al. Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies . J. Virol.88 ( 21 ), 12385 – 12396 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Buzon MJ , Martin-GayoE, PereyraFet al. Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells . J. Virol.88 ( 17 ), 10056 – 10065 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Buzon MJ , MassanellaM, LlibreJMet al. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects . Nat. Med.16 ( 4 ), 460 – 465 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Hatano H , ScherzerR, WuYet al. A randomized controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infection . J. Acquir. Immune Defic. Syndr.61 ( 3 ), 317 – 325 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Andres C , PlanaM, GuardoACet al. HIV-1 reservoir dynamics after vaccination and antiretroviral therapy interruption are associated with dendritic cell vaccine-induced T cell responses . J. Virol.89 ( 18 ), 9189 – 9199 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ruggiero A , De SpiegelaereW, Cozzi-LepriAet al. During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR/DP/DQ . EBioMedicine2 ( 9 ), 1153 – 1159 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Cockerham LR , SilicianoJD, SinclairEet al. CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells . PLoS ONE9 ( 10 ), e110731 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Darcis G , BouchatS, KulaAet al. Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir . AIDS31 ( 2 ), 181 – 189 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Pang S , KoyanagiY, MilesS, WileyC, VintersHV, ChenIS . High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients . Nature343 ( 6253 ), 85 – 89 ( 1990 ).
   PubMed Web of Science ®Google Scholar
• Vandegraaff N , KumarR, BurrellCJ, LiP . Kinetics of human immunodeficiency virus type 1 (HIV) DNA integration in acutely infected cells as determined using a novel assay for detection of integrated HIV DNA . J. Virol.75 ( 22 ), 11253 – 11260 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• De Spiegelaere W , MalatinkovaE, LynchLet al. Quantification of integrated HIV DNA by repetitive-sampling Alu-HIV PCR on the basis of poisson statistics . Clin. Chem.60 ( 6 ), 886 – 895 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Brussel A , DelelisO, SonigoP . Alu-LTR real-time nested PCR assay for quantifying integrated HIV-1 DNA . Methods Mol. Biol.304, 139 – 154 ( 2005 ).
   PubMedGoogle Scholar
• Agosto LM , YuJJ, DaiJ, KaletskyR, MonieD, O’dohertyU . HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration . Virology368 ( 1 ), 60 – 72 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Yu JJ , WuTL, LiszewskiMKet al. A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients . Virology379 ( 1 ), 78 – 86 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Brady T , KellyBJ, MaleFet al. Quantitation of HIV DNA integration: effects of differential integration site distributions on Alu-PCR assays . J. Virol. Methods189 ( 1 ), 53 – 57 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bush CE , DonovanRM, SmereckSM, StrangD, MarkowitzN, SaravolatzLD . Quantitation of unintegrated HIV-1 DNA in asymptomatic patients in the presence or absence of antiretroviral therapy . AIDS Res. Hum. Retroviruses9 ( 2 ), 183 – 187 ( 1993 ).
   PubMed Web of Science ®Google Scholar
• Donovan RM , BushCE, SmereckSM, MooreE, CohenF, SaravolatzLD . Antiretroviral therapy is associated with a decrease in unintegrated HIV-1 DNA in pediatric patients . J. Acquir. Immune Defic. Syndr.7 ( 12 ), 1237 – 1241 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Sonza S , MaerzA, DeaconN, MeangerJ, MillsJ, CroweS . Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes . J. Virol.70 ( 6 ), 3863 – 3869 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Gianella S , Von WylV, FischerMet al. Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA . Antivir. Ther.16 ( 4 ), 535 – 545 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Goujard C , GiraultI, RouziouxCet al. HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy . Antivir. Ther.17 ( 6 ), 1001 – 1009 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Ananworanich J , SchuetzA, VandergeetenCet al. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection . PLoS ONE7 ( 3 ), e33948 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Jain V , HartogensisW, BacchettiPet al. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size . J. Infect. Dis.208 ( 8 ), 1202 – 1211 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Pinzone MR , GrafE, LynchLet al. Monitoring integration over time supports a role for cytotoxic T lymphocytes and ongoing replication as determinants of reservoir size . J. Virol.90 ( 23 ), 10436 – 10445 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Besson GJ , LalamaCM, BoschRJet al. HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy . Clin. Infect. Dis.59 ( 9 ), 1312 – 1321 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Murray JM , ZaundersJJ, McbrideKLet al. HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy . J. Virol.88 ( 6 ), 3516 – 3526 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Rasmussen TA , TolstrupM, BrinkmannCRet al. Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a Phase I/II, single group, clinical trial . Lancet HIV1 ( 1 ), e13 – e21 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Elliott JH , WightmanF, SolomonAet al. Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy . PLoS Pathog.10 ( 10 ), e1004473 ( 2014 ).
   PubMedGoogle Scholar
• Yerly S , GunthardHF, FagardCet al. Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions . AIDS18 ( 14 ), 1951 – 1953 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Goujard C , BonarekM, MeyerLet al. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients . Clin. Infect. Dis.42 ( 5 ), 709 – 715 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Minga AK , AnglaretX, D’Aquin ToniTet al. HIV-1 DNA in peripheral blood mononuclear cells is strongly associated with HIV-1 disease progression in recently infected West African adults . J. Acquir. Immune Defic. Syndr.48 ( 3 ), 350 – 354 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Piketty C , WeissL, AssoumouLet al. A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir . J. Med. Virol.82 ( 11 ), 1819 – 1828 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Leth S , SchleimannMH, NissenSKet al. Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, Phase IB/IIA trial . Lancet HIV3 ( 10 ), e463 – e472 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Borducchi EN , CabralC, StephensonKEet al. Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys . Nature540 ( 7632 ), 284 – 287 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Maldarelli F , WuX, SuLet al. HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells . Science345 ( 6193 ), 179 – 183 ( 2014 ).
   PubMed Web of Science ®Google Scholar